VACC Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-01-02 | Pelletier Nadege | officer: Chief Scientific Officer | 105,000 | A-Award | A | 105,000 | 3.70 | 388,500.00 |
| 2024-01-02 | Griffiths Graham | officer: Chief Business Officer | 96,500 | A-Award | A | 96,500 | 3.70 | 357,050.00 |
| 2024-01-02 | Enright William | director, officer: Chief Executive Officer | 443,981 | A-Award | A | 443,981 | 3.70 | 1,642,730.00 |
| 2024-01-02 | Brown Gemma | officer: Chief Financial Officer | 193,000 | A-Award | A | 193,000 | 3.70 | 714,100.00 |
| 2023-06-26 | Scheeren Joseph | director | 23,000 | P-Purchase | A | 10,000 | 2.44 | 24,400.00 |
| 2023-05-25 | Wright Robin | director | 48,256 | P-Purchase | A | 13,750 | 2.66 | 36,612.00 |
| 2023-05-11 | Wright Robin | director | 19,197 | A-Award | A | 19,197 | 2.27 | 43,577.00 |
| 2023-05-11 | Scheeren Joseph | director | 19,197 | A-Award | A | 19,197 | 2.27 | 43,577.00 |
| 2023-05-11 | Phillips Anne M. | director | 19,197 | A-Award | A | 19,197 | 2.27 | 43,577.00 |
| 2023-05-11 | Morgon Pierre A. | director | 19,197 | A-Award | A | 19,197 | 2.27 | 43,577.00 |
| 2023-05-11 | Hammacher Alex | director | 19,197 | A-Award | A | 19,197 | 2.27 | 43,577.00 |
| 2023-05-11 | DAWES KAREN A | director | 19,197 | A-Award | A | 19,197 | 2.27 | 43,577.00 |
| 2023-01-03 | Marshall Margaret | officer: Chief Medical Officer | 60,000 | A-Award | A | 60,000 | 2.40 | 144,000.00 |
| 2023-01-03 | Evans Thomas George | officer: Fmr Chief Scientific Officer | 125,000 | A-Award | A | 125,000 | 2.40 | 300,000.00 |
| 2023-03-27 | Enright William | director, officer: Chief Executive Officer | 728,454 | S-Sale | D | 15,000 | 2.42 | 36,298.00 |
| 2023-02-01 | Pelletier Nadege | officer: Chief Scientific Officer | 485,000 | A-Award | A | 485,000 | 2.90 | 1,406,500.00 |
| 2023-01-30 | Pelletier Nadege | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-01-03 | Griffiths Graham | officer: Chief Business Officer | 105,000 | A-Award | A | 105,000 | 2.40 | 252,000.00 |
| 2023-01-03 | Enright William | director, officer: Chief Executive Officer | 440,000 | A-Award | A | 440,000 | 2.40 | 1,056,000.00 |
| 2023-01-03 | Ellis Christopher | officer: Chief Operating Officer | 105,000 | A-Award | A | 105,000 | 2.40 | 252,000.00 |
| 2023-01-03 | Brown Gemma | officer: Chief Financial Officer | 33,100 | A-Award | A | 33,100 | 2.40 | 79,440.00 |
| 2022-06-15 | Wright Robin | director | 18,604 | A-Award | A | 18,604 | 4.27 | 79,439.00 |
| 2022-06-15 | Scheeren Joseph | director | 18,604 | A-Award | A | 18,604 | 4.27 | 79,439.00 |
| 2022-06-15 | Phillips Anne M. | director | 18,604 | A-Award | A | 18,604 | 4.27 | 79,439.00 |
| 2022-06-15 | Morgon Pierre A. | director | 18,604 | A-Award | A | 18,604 | 4.27 | 79,439.00 |
| 2022-06-15 | Hammacher Alex | director | 18,604 | A-Award | A | 18,604 | 4.27 | 79,439.00 |
| 2022-06-15 | DAWES KAREN A | director | 18,604 | A-Award | A | 18,604 | 4.27 | 79,439.00 |
| 2022-09-30 | M&G Alternatives Investment Management Ltd | director | 0 | J-Other | D | 4,108,752 | 0.00 | 0.00 |
| 2022-09-30 | M&G INVESTMENT MANAGEMENT LTD | director | 5,197,349 | J-Other | A | 4,108,752 | 0.00 | 0.00 |
| 2022-09-26 | Brown Gemma | officer: Chief Financial Officer | 334,000 | A-Award | A | 334,000 | 3.07 | 1,025,380.00 |
| 2022-08-25 | Griffiths Graham | officer: Chief Business Officer | 104,209 | S-Sale | D | 10,000 | 7.39 | 73,870.00 |
| 2022-08-24 | Ellis Christopher | officer: Chief Operating Officer | 40,156 | M-Exempt | D | 450 | 0.00 | 0.00 |
| 2022-08-24 | Ellis Christopher | officer: Chief Operating Officer | 75 | S-Sale | D | 25,000 | 7.07 | 176,708.00 |
| 2022-08-17 | Ellis Christopher | officer: Chief Operating Officer | 40,606 | M-Exempt | D | 2,175 | 0.00 | 0.00 |
| 2022-08-17 | Ellis Christopher | officer: Chief Operating Officer | 75 | S-Sale | D | 2,175 | 4.84 | 10,531.00 |
| 2022-08-17 | Griffiths Graham | officer: Chief Business Officer | 114,209 | S-Sale | D | 500 | 4.76 | 2,381.00 |
| 2022-08-15 | Ellis Christopher | officer: Chief Operating Officer | 5,425 | M-Exempt | A | 5,350 | 0.00 | 2.14 |
| 2022-08-15 | Ellis Christopher | officer: Chief Operating Officer | 75 | S-Sale | D | 2,200 | 4.78 | 10,513.00 |
| 2022-08-15 | Griffiths Graham | officer: Chief Business Officer | 114,709 | S-Sale | D | 1,220 | 4.82 | 5,876.00 |
| 2022-08-12 | Griffiths Graham | officer: Chief Business Officer | 118,329 | S-Sale | D | 5,000 | 4.50 | 22,500.00 |
| 2022-06-28 | Ellis Christopher | officer: Chief Operating Officer | 80 | M-Exempt | A | 5 | 0.00 | 0.00 |
| 2022-06-28 | Ellis Christopher | officer: Chief Operating Officer | 75 | S-Sale | D | 5 | 6.00 | 30.00 |
| 2022-06-23 | Griffiths Graham | officer: Chief Business Officer | 123,329 | L-Small | A | 100 | 5.87 | 586.80 |
| 2022-06-23 | Griffiths Graham | officer: Chief Business Officer | 123,229 | S-Sale | D | 8 | 5.28 | 42.24 |
| 2022-06-23 | Griffiths Graham | officer: Chief Business Officer | 0 | M-Exempt | D | 1,931 | 0.00 | 0.00 |
| 2022-04-01 | Scheeren Joseph | director: | 13,000 | P-Purchase | A | 10,000 | 5.09 | 50,900.00 |
| 2022-03-31 | Hammacher Alex | director: | 3,000 | P-Purchase | A | 2,000 | 5.14 | 10,280.00 |
| 2021-12-17 | Griffiths Graham | officer: Chief Business Officer | 9,270 | M-Exempt | D | 3,090 | 0.00 | 1.24 |
| 2021-12-17 | Griffiths Graham | officer: Chief Business Officer | 4,634 | M-Exempt | D | 4,636 | 0.00 | 1.85 |
| 2021-12-17 | Griffiths Graham | officer: Chief Business Officer | 1,931 | M-Exempt | D | 5,794 | 0.00 | 2.32 |
| 2021-12-17 | Griffiths Graham | officer: Chief Business Officer | 0 | M-Exempt | D | 102,279 | 0.00 | 40.91 |
| 2022-01-03 | Marshall Margaret | officer: Chief Medical Officer | 80,000 | A-Award | A | 80,000 | 11.12 | 889,600.00 |
| 2022-01-03 | Griffiths Graham | officer: Chief Business Officer | 80,000 | A-Award | A | 80,000 | 11.12 | 889,600.00 |
| 2022-01-03 | Evans Thomas George | officer: Chief Scientific Officer | 80,000 | A-Award | A | 80,000 | 11.12 | 889,600.00 |
| 2022-01-03 | Ellis Christopher | officer: Chief Operating Officer | 80,000 | A-Award | A | 80,000 | 11.12 | 889,600.00 |
| 2022-01-03 | Enright William | director, officer: Chief Executive Officer | 359,605 | A-Award | A | 359,605 | 11.12 | 3,998,808.00 |
| 2022-01-03 | Egorov Georgy | officer: Chief Financial Officer | 114,000 | A-Award | A | 114,000 | 11.12 | 1,267,680.00 |
| 2021-12-31 | Hammacher Alex | director | 1,000 | P-Purchase | A | 1,000 | 10.86 | 10,860.00 |
| 2021-12-22 | Wright Robin | director | 34,506 | P-Purchase | A | 10,000 | 9.97 | 99,700.00 |
| 2021-04-29 | M&G Alternatives Investment Management Ltd | 10 percent owner | 4,108,752 | I | 0 | 0.00 | 0.00 | |
| 2021-05-04 | Enright William | director, officer: Chief Executive Officer | 1,258,377 | A-Award | A | 514,923 | 0.00 | 0.00 |
| 2021-05-04 | DAWES KAREN A | director | 1,700 | P-Purchase | A | 1,700 | 17.00 | 28,900.00 |
| 2021-05-04 | Griffiths Graham | officer: Chief Business Officer | 100 | P-Purchase | A | 100 | 17.00 | 1,700.00 |
| 2021-05-04 | Wright Robin | director | 24,506 | P-Purchase | A | 14,000 | 17.00 | 238,000.00 |
| 2021-05-04 | Ellis Christopher | officer: Chief Operating Officer | 75 | P-Purchase | A | 75 | 17.00 | 1,275.00 |
| 2021-05-04 | Scheeren Joseph | director | 3,000 | P-Purchase | A | 3,000 | 17.00 | 51,000.00 |
| 2021-05-04 | Phillips Anne M. | director | 3,000 | P-Purchase | A | 3,000 | 17.00 | 51,000.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 8,797,770 | P-Purchase | A | 600,000 | 17.00 | 10,200,000.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 8,197,770 | C-Conversion | A | 1,661,184 | 0.00 | 0.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 6,536,586 | C-Conversion | A | 1,704,444 | 0.00 | 0.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 4,832,142 | C-Conversion | A | 4,832,142 | 0.00 | 0.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 0 | C-Conversion | D | 1,661,184 | 0.00 | 0.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 0 | C-Conversion | D | 4,832,142 | 0.00 | 0.00 |
| 2021-05-04 | Oxford Sciences Innovation plc | 10 percent owner | 0 | C-Conversion | D | 1,704,444 | 0.00 | 0.00 |
| 2021-04-29 | Wright Robin | director | 34,328 | A-Award | A | 34,328 | 17.00 | 583,576.00 |
| 2021-04-29 | Scheeren Joseph | director | 34,328 | A-Award | A | 34,328 | 17.00 | 583,576.00 |
| 2021-04-29 | Phillips Anne M. | director | 34,328 | A-Award | A | 34,328 | 17.00 | 583,576.00 |
| 2021-04-29 | Morgon Pierre A. | director | 34,328 | A-Award | A | 34,328 | 17.00 | 583,576.00 |
| 2021-04-29 | Hammacher Alex | director | 34,328 | A-Award | A | 34,328 | 17.00 | 583,576.00 |
| 2021-04-29 | DAWES KAREN A | director | 34,328 | A-Award | A | 34,328 | 17.00 | 583,576.00 |
| 2021-04-29 | Enright William | director, officer: Chief Executive Officer | 1,199,229 | A-Award | A | 455,775 | 0.00 | 0.00 |
| 2021-04-29 | Enright William | director, officer: Chief Executive Officer | 176,130 | A-Award | A | 176,130 | 17.00 | 2,994,210.00 |
| 2021-04-29 | Marshall Margaret | officer: Chief Medical Officer | 225,570 | A-Award | A | 225,570 | 17.00 | 3,834,690.00 |
| 2021-04-29 | Marshall Margaret | officer: Chief Medical Officer | 7,783 | A-Award | A | 7,783 | 17.00 | 132,311.00 |
| 2021-04-29 | Griffiths Graham | officer: Chief Business Officer | 88,065 | A-Award | A | 88,065 | 17.00 | 1,497,105.00 |
| 2021-04-29 | Griffiths Graham | officer: Chief Business Officer | 6,054 | A-Award | A | 6,054 | 17.00 | 102,918.00 |
| 2021-04-29 | Evans Thomas George | officer: Chief Scientific Officer | 364,620 | A-Award | A | 364,620 | 17.00 | 6,198,540.00 |
| 2021-04-29 | Evans Thomas George | officer: Chief Scientific Officer | 6,942 | A-Award | A | 6,942 | 17.00 | 118,014.00 |
| 2021-04-29 | Ellis Christopher | officer: Chief Operating Officer | 97,335 | A-Award | A | 97,335 | 17.00 | 1,654,695.00 |
| 2021-04-29 | Ellis Christopher | officer: Chief Operating Officer | 5,708 | A-Award | A | 5,708 | 17.00 | 97,036.00 |
| 2021-04-29 | Egorov Georgy | officer: Chief Financial Officer | 149,865 | A-Award | A | 149,865 | 17.00 | 2,547,705.00 |
| 2021-04-29 | Egorov Georgy | officer: Chief Financial Officer | 6,918 | A-Award | A | 6,918 | 17.00 | 117,606.00 |
| 2021-04-30 | M&G INVESTMENT MANAGEMENT LTD | 10 percent owner | 1,088,597 | P-Purchase | A | 125,000 | 14.40 | 1,800,000.00 |
| 2021-04-29 | M&G INVESTMENT MANAGEMENT LTD | 10 percent owner | 963,597 | I | 0 | 0.00 | 0.00 | |
| 2021-04-29 | Oxford Sciences Innovation plc | 10 percent owner | 0 | D | 4,832,142 | 0.00 | 0.00 | |
| 2021-04-29 | Oxford Sciences Innovation plc | 10 percent owner | 0 | D | 1,704,444 | 0.00 | 0.00 | |
| 2021-04-29 | Oxford Sciences Innovation plc | 10 percent owner | 0 | D | 1,661,184 | 0.00 | 0.00 | |
| 2021-04-29 | Scheeren Joseph | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-04-29 | Phillips Anne M. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-04-29 | Morgon Pierre A. | director | 10,506 | D | 0 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
